Found: 47
Select item for more details and to access through your institution.
Evaluation of classical clinical endpoints as surrogates for overall survival in patients treated with immune checkpoint blockers: a systematic review and meta-analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 11, p. 2245, doi. 10.1007/s00432-018-2738-x
- By:
- Publication type:
- Article
BOOK REVIEWS.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 19, p. 1527
- By:
- Publication type:
- Article
Pilot Study of Interleukin-2 and Lymphokine-Activated Killer Cells Combined With Immunomodulatory Doses of Chemotherapy and Sequenced With Interferon Alfa-2a in Patients With Metastatic Melanoma and Renal Cell Carcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 12, p. 929
- By:
- Publication type:
- Article
Phase I Study of High-Dose Continuous-Infusion Recombinant Interleukin-2 and Autologous Lymphokine-Activated Killer Cells in Patients With Metastatic or Unresectable Malignant Melanoma and Renal Cell Carcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 17, p. 1397
- By:
- Publication type:
- Article
Use of Prophylactic Antibiotics for Prevention of Intravascular Catheter-Related Infections in Interleukin-2-Treated Patients12.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1989, v. 81, n. 15, p. 1190
- By:
- Publication type:
- Article
Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correction.
- Published in:
- EMBO Molecular Medicine, 2024, v. 16, n. 9, p. 2188, doi. 10.1038/s44321-024-00115-0
- By:
- Publication type:
- Article
Outcomes With Combination Pembrolizumab and Axitinib in Second and Further Line Treatment of Metastatic Renal Cell Carcinoma.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 2, p. 221, doi. 10.1016/j.clgc.2023.01.002
- By:
- Publication type:
- Article
Immunotherapy utilization in stage IIIA melanoma: less may be more.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1336441
- By:
- Publication type:
- Article
Author Correction: Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28566-4
- By:
- Publication type:
- Article
Phase Ib Study of Atezolizumab Plus Interferon-β with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors.
- Published in:
- Current Oncology, 2021, v. 28, n. 6, p. 5466, doi. 10.3390/curroncol28060455
- By:
- Publication type:
- Article
Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.
- Published in:
- Nature Genetics, 2015, v. 47, n. 9, p. 996, doi. 10.1038/ng.3361
- By:
- Publication type:
- Article
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.
- Published in:
- Nature Genetics, 2012, v. 44, n. 9, p. 1006, doi. 10.1038/ng.2359
- By:
- Publication type:
- Article
A Melanoma Brain Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: First Evidence for Fusion in Human Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066731
- By:
- Publication type:
- Article
Integrative Analysis of Epigenetic Modulation in Melanoma Cell Response to Decitabine: Clinical Implications.
- Published in:
- PLoS ONE, 2009, v. 4, n. 2, p. 1, doi. 10.1371/journal.pone.0004563
- By:
- Publication type:
- Article
Betting on immunotherapy for melanoma.
- Published in:
- Current Oncology Reports, 2009, v. 11, n. 5, p. 397, doi. 10.1007/s11912-009-0053-z
- By:
- Publication type:
- Article
The Expanding Role of Immunotherapy: "An enormous number of promising new agents".
- Published in:
- Oncology (08909091), 2020, v. 34, n. 10, p. 427
- By:
- Publication type:
- Article
Advances in the Systemic Treatment of Metastatic Melanoma.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 5, p. 1
- By:
- Publication type:
- Article
A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumors.
- Published in:
- 1993
- By:
- Publication type:
- journal article
A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 2, p. 123, doi. 10.1007/s10637-005-5857-6
- By:
- Publication type:
- Article
CD4 T cells and toxicity from immune checkpoint blockade.
- Published in:
- Immunological Reviews, 2023, v. 318, n. 1, p. 96, doi. 10.1111/imr.13248
- By:
- Publication type:
- Article
Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 7, p. 1, doi. 10.1007/s00018-022-04364-5
- By:
- Publication type:
- Article
Early B cell changes predict autoimmunity following combination immune checkpoint blockade.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients.
- Published in:
- Cancer Gene Therapy, 2003, v. 10, n. 10, p. 737, doi. 10.1038/sj.cgt.7700634
- By:
- Publication type:
- Article
Phase I Trial of Triapine-Cisplatin-Paclitaxel Chemotherapy for advanced Stage or Metastatic Solid Tumor Cancers.
- Published in:
- Frontiers in Oncology, 2017, v. 7, p. 1, doi. 10.3389/fonc.2017.00062
- By:
- Publication type:
- Article
Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma.
- Published in:
- Nature Communications, 2016, v. 7, n. 8, p. 12624, doi. 10.1038/ncomms12624
- By:
- Publication type:
- Article
Immune Modulation Therapy and Imaging: Workshop Report.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 3, p. 410, doi. 10.2967/jnumed.117.195610
- By:
- Publication type:
- Article
A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01884-x
- By:
- Publication type:
- Article
Phase I trial of daily triapine in combination with cisplatin chemotherapy for advanced-stage malignancies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 54, n. 4, p. 331, doi. 10.1007/s00280-004-0821-2
- By:
- Publication type:
- Article
Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 232, p. 1, doi. 10.1126/scitranslmed.3008068
- By:
- Publication type:
- Article
Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6th-7th 2010".
- Published in:
- 2011
- By:
- Publication type:
- research
Incidence of the V600K mutation amongmelanoma patients with BRAF mutations, andpotential therapeutic response to the specificBRAF inhibitor PLX4032.
- Published in:
- Journal of Translational Medicine, 2010, v. 8, p. 67, doi. 10.1186/1479-5876-8-67
- By:
- Publication type:
- Article
Melanoma: A model for testing new agents in combination therapies.
- Published in:
- Journal of Translational Medicine, 2010, v. 8, p. 38, doi. 10.1186/1479-5876-8-38
- By:
- Publication type:
- Article
The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.
- Published in:
- Journal of Translational Medicine, 2007, v. 5, p. 6, doi. 10.1186/1479-5876-5-6
- By:
- Publication type:
- Article
A phase 2 trial of dasatinib in advanced melanoma.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 10, p. 2202, doi. 10.1002/cncr.25766
- By:
- Publication type:
- Article
Clinical Predictors of Survival in Patients With BRAFV600-Mutated Metastatic Melanoma Treated With Combined BRAF and MEK Inhibitors After Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2024, v. 29, n. 4, p. e507, doi. 10.1093/oncolo/oyad300
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.836859
- By:
- Publication type:
- Article
Causes of death and patterns of metastatic disease at the end of life for patients with advanced melanoma in the immunotherapy era.
- Published in:
- Pigment Cell & Melanoma Research, 2024, v. 37, n. 6, p. 847, doi. 10.1111/pcmr.13188
- By:
- Publication type:
- Article
Biology of advanced uveal melanoma and next steps for clinical therapeutics.
- Published in:
- Pigment Cell & Melanoma Research, 2015, v. 28, n. 2, p. 135, doi. 10.1111/pcmr.12304
- By:
- Publication type:
- Article
In vitro studies of dasatinib, its targets and predictors of sensitivity.
- Published in:
- Pigment Cell & Melanoma Research, 2011, v. 24, n. 2, p. 386, doi. 10.1111/j.1755-148X.2011.00835.x
- By:
- Publication type:
- Article
PLX4032, a selective BRAF<sup>V600E</sup> kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF<sup>WT</sup> melanoma cells.
- Published in:
- Pigment Cell & Melanoma Research, 2010, v. 23, n. 2, p. 190, doi. 10.1111/j.1755-148X.2010.00685.x
- By:
- Publication type:
- Article
Determinants of overall survival in patients with metastatic uveal melanoma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 20, p. 3275, doi. 10.1002/cncr.34927
- By:
- Publication type:
- Article
Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival.
- Published in:
- Journal of Neurosurgery, 2012, v. 117, n. 2, p. 227, doi. 10.3171/2012.5.JNS111929
- By:
- Publication type:
- Article
Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy.
- Published in:
- Diabetes Care, 2015, v. 38, n. 4, p. e55, doi. 10.2337/dc14-2349
- By:
- Publication type:
- Article
Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors.
- Published in:
- 2018
- By:
- Publication type:
- journal article